These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

152 related items for PubMed ID: 3329453

  • 21. [Measurements of prostatic acid phosphatase and prostate specific antigen by fully automated enzyme immunoassay system--its analytical and clinical evaluation].
    Matui A, Yamada T, Sugita O, Yakata M.
    Rinsho Byori; 1990 Jun; 38(6):693-8. PubMed ID: 1696328
    [Abstract] [Full Text] [Related]

  • 22. [Changes in prostatic acid phosphatase, gamma-seminoprotein and prostate specific antigen after endocrine therapy for stage D2 prostate cancer].
    Akimoto S, Akakura K, Masai M, Isaka S, Shimazaki J.
    Hinyokika Kiyo; 1990 Jul; 36(7):783-91. PubMed ID: 1700588
    [Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24. [Specific quantification of gamma-seminoprotein-alpha 1 antichymotrypsin complex in serum by monoclonal antibody-based enzyme immunoassay].
    Chichibu K, Kuroe K, Hashimoto C, Goto S.
    Rinsho Byori; 1995 Nov; 43(11):1153-8. PubMed ID: 8551680
    [Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30. [The clinical significance of serum tissue polypeptide antigen as a tumor marker for urogenital carcinomas--a comparison with other tumor markers in patients with renal cell carcinoma and prostatic carcinoma].
    Yamazaki K, Kumamoto Y, Tsukamoto T, Umehara T, Ohmura K.
    Hinyokika Kiyo; 1987 Oct; 33(10):1581-9. PubMed ID: 2451408
    [Abstract] [Full Text] [Related]

  • 31. Clinical evaluation of gamma-seminoprotein in prostate cancer.
    Kuriyama M, Takeuchi T, Shinoda I, Okano M, Nishiura T.
    Prostate; 1986 Oct; 8(3):301-11. PubMed ID: 2422639
    [Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35. [Clinical significance of gamma-seminoprotein assay as a tumor marker].
    Eto K, Ueda S.
    Nihon Rinsho; 1990 Feb; 48 Suppl():920-4. PubMed ID: 2192175
    [No Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40. Measurement of prostate specific antigen and gamma-seminoprotein ratio: a new means of distinguishing benign prostatic hyperplasia and prostate cancer.
    Demura T, Watarai Y, Togashi M, Hirano T, Ohashi N, Koyanagi T.
    J Urol; 1993 Nov; 150(5 Pt 2):1740-5. PubMed ID: 7692111
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 8.